Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
3(100.0%)
3Total
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06810310Phase 2Recruiting

Psilocybin on Brain Mechanisms of Motivation in OUD

Role: lead

NCT06786325Phase 2Recruiting

Wellcome Leap Psilocybin for OUD

Role: lead

NCT03430544Phase 2Terminated

Cariprazine Effects on Brain and Behavior in Cocaine Use Disorder

Role: lead

All 3 trials loaded